Theromics

Investors · 2

BE

Beacon AngelsBoston · $50K – $400K

MA

Maroon Venture Partners FundAmherst · $100K – $300Kvia Charlie Johnson · inferred

$2.3M disclosed across 4 rounds · 2018–2023

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

PH

Phinomics4 shared keywordsPhinomics is a cancer drug discovery platform that captures extrachromosomal circular DNA (the "Circulome") at high resolution from matched tumor and normal patient samples, integrating it with DNA, RNA, epigenetics, and proteomics into a multi-omic knowledge graph. It applies explainable AI to this data to identify novel therapeutic targets, resistance mechanisms, and patient stratification biomarkers for oncology therapeutics development.

XD

XDemics4 shared keywordsXDemics builds Expansify cell culture plates that use a gas-permeable material and geometric design to enable high-density growth of T cells, viral vectors, stem cells, proteins, and organoids at yields far above conventional cultureware. Its ANSI/SLAS-footprint, liquid-handler-compatible formats serve cell therapy and bioprocessing research and production workflows with linear scaleup from lab plates to bioreactors.

TA

Tagomics4 shared keywordsTagomics is focused on organ health, though the available page content does not provide enough detail about its products, technology, or business model.

Companies competing with Theromics for the same Google search keywords, organic and paid, via search-intersection analysis.

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.